EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic Characteristics of Bladder Cancer: An AACR Project GENIE Study

John Paul Braun iD, Kenneth A D Palattao iD, Elijah Torbenson, Beau Hsia iD, Abubakar Tauseef

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von John Paul Braun und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Creighton University, Omaha, NE 68178, USA. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder and urothelial carcinoma are marked by profound genomic diversity. Using a large, multi-institutional dataset, we performed comprehensive genomic profiling of 4631 tumor samples from 4050 individuals. A retrospective analysis of bladder and urothelial cancer was performed using the AACR Project GENIE database. Demographic associations, mutation frequencies, copy number changes, and survival correlations were analyzed with a p-value < 0.05. Frequent mutations were identified in TP53, TERT, KDM6A, KMT2D, ARID1A, and FGFR3. Mutation frequencies varied by sex and race, with specific alterations enriched in female and Asian patients. Distinct patterns of co-occurrence, including TP53 with RB1, and mutual exclusivity, including TP53 with FGFR3 or KDM6A, revealed distinct molecular subtypes. This study highlights the extensive heterogeneity of bladder cancer, and our findings emphasize the clinical importance of molecular stratification and support the need for further mechanistic and prospective studies to inform the development of targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsHumansFemaleMaleMutationDNA Copy Number VariationsGenomicsReceptor, Fibroblast Growth Factor, Type 3Tumor Suppressor Protein p53Middle AgedAgedHistone DemethylasesTelomeraseTranscription FactorsRetrospective StudiesDNA-Binding ProteinsRetinoblastoma Binding ProteinsNuclear ProteinsMutation RateNeoplasm ProteinsUbiquitin-Protein Ligases

Stichwörter der Autor:innen

AACR Project GENIEbladder cancercopy number alterationsdemographic disparitiesgenomic profilingsomatic mutationstargeted therapyurothelial carcinoma

Substanzen

Receptor, Fibroblast Growth Factor, Type 3FGFR3 protein, humanTumor Suppressor Protein p53KDM6A protein, humanHistone DemethylasesTelomeraseTranscription FactorsARID1A protein, humanDNA-Binding ProteinsTERT protein, human

Autor:innen und Institutionen

  • School of Medicine, Creighton University, Omaha, NE 68178, USA.
  • School of Medicine, Creighton University, Phoenix, AZ 85012, USA.
  • Department of Internal Medicine, School of Medicine, Creighton University, Omaha, NE 68178, USA.

ORCID-Profile: John Paul Braun, Kenneth A D Palattao, Beau Hsia

Zitieren

APA

Braun, J. P., Palattao, K. A. D., Torbenson, E., Hsia, B., & Tauseef, A. (2025). Genomic Characteristics of Bladder Cancer: An AACR Project GENIE Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311653

Vancouver

Braun JP, Palattao KAD, Torbenson E, Hsia B, Tauseef A. Genomic Characteristics of Bladder Cancer: An AACR Project GENIE Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311653

BibTeX
@article{Braun2025,
  author = {Braun, John Paul and Palattao, Kenneth A D and Torbenson, Elijah and Hsia, Beau and Tauseef, Abubakar},
  title = {Genomic Characteristics of Bladder Cancer: An AACR Project GENIE Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311653}
}
Kostenlos starten →